APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pentavalent Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pentavalent Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025184 pages

Choose your research edition.

Industry ResearchPentavalent Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pentavalent Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pentavalent Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pentavalent Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pentavalent Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pentavalent Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pentavalent Vaccine include Bio Farma, Biological E. Ltd., Crucell, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Novartis AG and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pentavalent Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pentavalent Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pentavalent Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pentavalent Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pentavalent Vaccine Segment by Company

Bio Farma

Biological E. Ltd.

Crucell

Panacea Drugs Pvt. Ltd

Shantha Biotechnics

Novartis AG

Serum Institute of India

Pentavalent Vaccine Segment by Type

Lyophilized

Liquid

Pentavalent Vaccine Segment by Application

Hospital Pharmacy

Retail Pharmacy

E-commerce

Pentavalent Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pentavalent Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pentavalent Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pentavalent Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pentavalent Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pentavalent Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pentavalent Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pentavalent Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pentavalent Vaccine Industry Trends Table 2. Pentavalent Vaccine Industry Drivers Table 3. Pentavalent Vaccine Industry Opportunities and Challenges Table 4. Pentavalent Vaccine Industry Restraints Table 5. Global Pentavalent Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pentavalent Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pentavalent Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pentavalent Vaccine Sales Market Share by Manufacturers Table 9. Global Pentavalent Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pentavalent Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pentavalent Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pentavalent Vaccine Manufacturers, Product Type & Application Table 13. Global Pentavalent Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pentavalent Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lyophilized Table 17. Major Manufacturers of Liquid Table 18. Global Pentavalent Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Pentavalent Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Pentavalent Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Pentavalent Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Pentavalent Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pentavalent Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Pentavalent Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Pentavalent Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Pharmacy Table 29. Major Manufacturers of Retail Pharmacy Table 30. Major Manufacturers of E-commerce Table 31. Global Pentavalent Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 33. Global Pentavalent Vaccine Sales by Application (2027-2032) & (k units) Table 34. Global Pentavalent Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Pentavalent Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Pentavalent Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pentavalent Vaccine Revenue by Application (2021-2026) & (k units) Table 38. Global Pentavalent Vaccine Revenue by Application (2027-2032) & (k units) Table 39. Global Pentavalent Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Pentavalent Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Pentavalent Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pentavalent Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Pentavalent Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Pentavalent Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Pentavalent Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 48. North America Pentavalent Vaccine Sales by Country (2027-2032) & (k units) Table 49. Europe Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 51. Europe Pentavalent Vaccine Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Pentavalent Vaccine Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Pentavalent Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Pentavalent Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pentavalent Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pentavalent Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pentavalent Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Pentavalent Vaccine Revenue Market Share by Region (2027-2032) Table 63. Bio Farma Company Information Table 64. Bio Farma Business Overview Table 65. Bio Farma Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bio Farma Pentavalent Vaccine Product Portfolio Table 67. Bio Farma Recent Development Table 68. Biological E. Ltd. Company Information Table 69. Biological E. Ltd. Business Overview Table 70. Biological E. Ltd. Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Biological E. Ltd. Pentavalent Vaccine Product Portfolio Table 72. Biological E. Ltd. Recent Development Table 73. Crucell Company Information Table 74. Crucell Business Overview Table 75. Crucell Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Crucell Pentavalent Vaccine Product Portfolio Table 77. Crucell Recent Development Table 78. Panacea Drugs Pvt. Ltd Company Information Table 79. Panacea Drugs Pvt. Ltd Business Overview Table 80. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolio Table 82. Panacea Drugs Pvt. Ltd Recent Development Table 83. Shantha Biotechnics Company Information Table 84. Shantha Biotechnics Business Overview Table 85. Shantha Biotechnics Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shantha Biotechnics Pentavalent Vaccine Product Portfolio Table 87. Shantha Biotechnics Recent Development Table 88. Novartis AG Company Information Table 89. Novartis AG Business Overview Table 90. Novartis AG Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Novartis AG Pentavalent Vaccine Product Portfolio Table 92. Novartis AG Recent Development Table 93. Serum Institute of India Company Information Table 94. Serum Institute of India Business Overview Table 95. Serum Institute of India Pentavalent Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Serum Institute of India Pentavalent Vaccine Product Portfolio Table 97. Serum Institute of India Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Pentavalent Vaccine Distributors List Table 101. Pentavalent Vaccine Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Pentavalent Vaccine Product Image Figure 2. Global Pentavalent Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pentavalent Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pentavalent Vaccine Sales (2021-2032) & (k units) Figure 5. Global Pentavalent Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pentavalent Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lyophilized Image Figure 9. Liquid Image Figure 10. Global Pentavalent Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pentavalent Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pentavalent Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Pentavalent Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pentavalent Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pentavalent Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Pharmacy Image Figure 17. Retail Pharmacy Image Figure 18. E-commerce Image Figure 19. Global Pentavalent Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pentavalent Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pentavalent Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Pentavalent Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pentavalent Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pentavalent Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Pentavalent Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pentavalent Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pentavalent Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pentavalent Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Pentavalent Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Pentavalent Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pentavalent Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pentavalent Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pentavalent Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pentavalent Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pentavalent Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pentavalent Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pentavalent Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized
  • Liquid
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce
Companies covered
  • Bio Farma
  • Biological E. Ltd.
  • Crucell
  • Panacea Drugs Pvt. Ltd
  • Shantha Biotechnics
  • Novartis AG
  • Serum Institute of India

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pentavalent Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pentavalent Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pentavalent Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pentavalent Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pentavalent Vaccine Market Dynamics
  1. 2.1 Pentavalent Vaccine Industry Trends
  2. 2.2 Pentavalent Vaccine Industry Drivers
  3. 2.3 Pentavalent Vaccine Industry Opportunities and Challenges
  4. 2.4 Pentavalent Vaccine Industry Restraints
3 Pentavalent Vaccine Market by Manufacturers
  1. 3.1 Global Pentavalent Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pentavalent Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pentavalent Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pentavalent Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pentavalent Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pentavalent Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Pentavalent Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pentavalent Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pentavalent Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pentavalent Vaccine Tier 1, Tier 2, and Tier 3
4 Pentavalent Vaccine Market by Type
  1. 4.1 Pentavalent Vaccine Type Introduction
  2. 4.1.1 Lyophilized
  3. 4.1.2 Liquid
  4. 4.2 Global Pentavalent Vaccine Sales by Type
  5. 4.2.1 Global Pentavalent Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pentavalent Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Pentavalent Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pentavalent Vaccine Revenue by Type
  9. 4.3.1 Global Pentavalent Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pentavalent Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Pentavalent Vaccine Revenue Market Share by Type (2021-2032)
5 Pentavalent Vaccine Market by Application
  1. 5.1 Pentavalent Vaccine Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 E-commerce
  5. 5.2 Global Pentavalent Vaccine Sales by Application
  6. 5.2.1 Global Pentavalent Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pentavalent Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Pentavalent Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pentavalent Vaccine Revenue by Application
  10. 5.3.1 Global Pentavalent Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pentavalent Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Pentavalent Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pentavalent Vaccine Sales by Region
  1. 6.1 Global Pentavalent Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pentavalent Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pentavalent Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Pentavalent Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pentavalent Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pentavalent Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pentavalent Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pentavalent Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pentavalent Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pentavalent Vaccine Revenue by Region
  1. 7.1 Global Pentavalent Vaccine Revenue by Region
  2. 7.1.1 Global Pentavalent Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pentavalent Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pentavalent Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pentavalent Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pentavalent Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pentavalent Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pentavalent Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pentavalent Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pentavalent Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio Farma
  2. 8.1.1 Bio Farma Company Information
  3. 8.1.2 Bio Farma Business Overview
  4. 8.1.3 Bio Farma Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bio Farma Pentavalent Vaccine Product Portfolio
  6. 8.1.5 Bio Farma Recent Developments
  7. 8.2 Biological E. Ltd.
  8. 8.2.1 Biological E. Ltd. Company Information
  9. 8.2.2 Biological E. Ltd. Business Overview
  10. 8.2.3 Biological E. Ltd. Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biological E. Ltd. Pentavalent Vaccine Product Portfolio
  12. 8.2.5 Biological E. Ltd. Recent Developments
  13. 8.3 Crucell
  14. 8.3.1 Crucell Company Information
  15. 8.3.2 Crucell Business Overview
  16. 8.3.3 Crucell Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Crucell Pentavalent Vaccine Product Portfolio
  18. 8.3.5 Crucell Recent Developments
  19. 8.4 Panacea Drugs Pvt. Ltd
  20. 8.4.1 Panacea Drugs Pvt. Ltd Company Information
  21. 8.4.2 Panacea Drugs Pvt. Ltd Business Overview
  22. 8.4.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolio
  24. 8.4.5 Panacea Drugs Pvt. Ltd Recent Developments
  25. 8.5 Shantha Biotechnics
  26. 8.5.1 Shantha Biotechnics Company Information
  27. 8.5.2 Shantha Biotechnics Business Overview
  28. 8.5.3 Shantha Biotechnics Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shantha Biotechnics Pentavalent Vaccine Product Portfolio
  30. 8.5.5 Shantha Biotechnics Recent Developments
  31. 8.6 Novartis AG
  32. 8.6.1 Novartis AG Company Information
  33. 8.6.2 Novartis AG Business Overview
  34. 8.6.3 Novartis AG Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis AG Pentavalent Vaccine Product Portfolio
  36. 8.6.5 Novartis AG Recent Developments
  37. 8.7 Serum Institute of India
  38. 8.7.1 Serum Institute of India Company Information
  39. 8.7.2 Serum Institute of India Business Overview
  40. 8.7.3 Serum Institute of India Pentavalent Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Pentavalent Vaccine Product Portfolio
  42. 8.7.5 Serum Institute of India Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pentavalent Vaccine Value Chain Analysis
  2. 9.1.1 Pentavalent Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pentavalent Vaccine Production Mode & Process
  6. 9.2 Pentavalent Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pentavalent Vaccine Distributors
  9. 9.2.3 Pentavalent Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst